Efficacy and safety of apatinib plus docetaxel for non-squamous non-small cell lung cancer with bone metastases.

被引：0
|
作者：
Zang, Aimin
Sun, Guoguo
机构：
[1] Hebei Med Univ, Affiliate Hosp, Baoding, Peoples R China
[2] Tangshan Peoples Hosp, Tangshan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21741
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small Cell Lung Cancer
    Wu, Feng Ying
    Zhang, Shi Jia
    Ren, Sheng Xiang
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1286 - S1287
  • [2] Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases
    Takaaki Tokito
    Takehito Shukuya
    Hiroaki Akamatsu
    Tetsuhiko Taira
    Akira Ono
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Toshiaki Takahashi
    Masahiro Endo
    Nobuyuki Yamamoto
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1493 - 1498
  • [3] Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases
    Tokito, Takaaki
    Shukuya, Takehito
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1493 - 1498
  • [4] Efficacy and safety of bevacizumab in nonsquamous non-small cell lung cancer with brain metastases.
    Ichiki, Masao
    Yoshida, Tsukasa
    Nakamura, Masayuki
    Kumano, Tomomi
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    LUNG CANCER, 2019, 135 : 104 - 109
  • [7] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [8] Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non-small cell lung cancer: A meta-analysis
    Li, Zhe
    Liu, Zhibao
    Wu, Yuanyuan
    Li, Huarui
    Sun, Zhen
    Han, Chenggang
    Zhang, Xiaoling
    Zhang, Jinghua
    THORACIC CANCER, 2021, 12 (21) : 2838 - 2848
  • [9] Efficacy and safety of camrelizumab plus apatinib as second-line treatment for advanced squamous non-small cell lung cancer
    Gao, Guanghui
    Zhao, Jun
    Ren, Shengxiang
    Wang, Yina
    Chen, Gongyan
    Chen, Jianhua
    Gu, Kangsheng
    Guo, Renhua
    Pan, Yueyin
    Wang, Quanren
    Li, Weixia
    Yang, Xinfeng
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (08)
  • [10] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    LUNG CANCER, 2019, 129 : 35 - 40
12345